ZA200203311B - Pharmaceutical carrier formulation. - Google Patents

Pharmaceutical carrier formulation.

Info

Publication number
ZA200203311B
ZA200203311B ZA200203311A ZA200203311A ZA200203311B ZA 200203311 B ZA200203311 B ZA 200203311B ZA 200203311 A ZA200203311 A ZA 200203311A ZA 200203311 A ZA200203311 A ZA 200203311A ZA 200203311 B ZA200203311 B ZA 200203311B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical carrier
carrier formulation
formulation
pharmaceutical
carrier
Prior art date
Application number
ZA200203311A
Other languages
English (en)
Inventor
Joseph Kyuwung Yoon
Mahdi Bakir Fawzi
Richard William Saunders
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA200203311B publication Critical patent/ZA200203311B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200203311A 1999-09-27 2002-04-25 Pharmaceutical carrier formulation. ZA200203311B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27

Publications (1)

Publication Number Publication Date
ZA200203311B true ZA200203311B (en) 2003-12-31

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200203311A ZA200203311B (en) 1999-09-27 2002-04-25 Pharmaceutical carrier formulation.

Country Status (18)

Country Link
EP (1) EP1216029A1 (zh)
JP (1) JP2003510267A (zh)
KR (1) KR20020064289A (zh)
CN (1) CN1399542A (zh)
AR (1) AR025867A1 (zh)
AU (1) AU7716100A (zh)
BR (1) BR0014308A (zh)
CA (1) CA2388471A1 (zh)
CZ (1) CZ20021082A3 (zh)
EA (1) EA200200415A1 (zh)
HK (1) HK1044485A1 (zh)
HU (1) HUP0202652A3 (zh)
IL (1) IL148543A0 (zh)
MX (1) MXPA02003190A (zh)
NO (1) NO20021476L (zh)
PL (1) PL354331A1 (zh)
WO (1) WO2001022942A1 (zh)
ZA (1) ZA200203311B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
JPWO2004073692A1 (ja) * 2003-02-18 2006-06-01 山下　伸二 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
JP5406529B2 (ja) 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
US20100093725A1 (en) * 2006-10-31 2010-04-15 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
JP7268012B2 (ja) * 2017-12-20 2023-05-02 フイルメニツヒ ソシエテ アノニム 口腔ケア組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
US5599808A (en) * 1994-02-18 1997-02-04 Cephalon, Inc. Aqueous indolocarbazole solutions
ATE429210T1 (de) * 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen

Also Published As

Publication number Publication date
MXPA02003190A (es) 2002-09-30
CA2388471A1 (en) 2001-04-05
EA200200415A1 (ru) 2002-10-31
BR0014308A (pt) 2002-05-21
HK1044485A1 (zh) 2002-10-25
NO20021476D0 (no) 2002-03-25
IL148543A0 (en) 2002-09-12
KR20020064289A (ko) 2002-08-07
HUP0202652A2 (hu) 2004-05-28
JP2003510267A (ja) 2003-03-18
CN1399542A (zh) 2003-02-26
AU7716100A (en) 2001-04-30
WO2001022942A1 (en) 2001-04-05
PL354331A1 (en) 2004-01-12
NO20021476L (no) 2002-04-16
EP1216029A1 (en) 2002-06-26
HUP0202652A3 (en) 2004-06-28
AR025867A1 (es) 2002-12-18
CZ20021082A3 (cs) 2002-06-12

Similar Documents

Publication Publication Date Title
HK1045650A1 (en) Pharmaceutical composition.
ZA993338B (en) Pharmaceutical formulations.
ZA200200743B (en) Preserved pharmaceutical formulations.
EG24226A (en) Formulation
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200203486B (en) Novel pharmaceutical compositions.
ZA200203707B (en) Pharmaceutical combinations.
ZA200000857B (en) Pharmaceutical composition.
GB9905898D0 (en) Controlled-dose formulation
HK1040488A1 (en) Pharmaceutical formulations.
GB9902304D0 (en) Formulation
ZA200203311B (en) Pharmaceutical carrier formulation.
ZA200110454B (en) Pharmaceutical complex.
GB9909154D0 (en) Pharmaceutical formulation
HK1046133A1 (en) Pharmaceutical compounds.
GB9926251D0 (en) Pharmaceutical formulation
ZA994697B (en) Pharmaceutical formulation.
ZA99918B (en) Pharmaceutical formulation.
ZA200107074B (en) Pharmaceutical composition based on polyaromatic compounds.
ZA99349B (en) A pharmaceutical formulation.
GB9902236D0 (en) Formulation
GB9921396D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation